Dexcom ONE Now Available in France
On September 12, 2023, Dexcom, a world leader in real-time continuous glucose monitoring (CGM) systems, announced that their Dexcom ONE system will now be available in France for people with diabetes.
This achievement in access to diabetes technology is a major win for people with diabetes and it will bring this lifesaving technology to half a million more people with diabetes in France.
What CGMs do + why they’re important
CGMs are a crucial tool for people with diabetes. In contrast to manually testing blood sugar levels with a glucometer, a CGM is a small device worn externally that continuously reads blood sugar levels.
The blood sugar level readings are then shown on a connecting device, such as a receiver, insulin pump or on an app on a phone. A CGM will also show trend lines, which can help you anticipate future blood sugar levels, plan meals more precisely or exercise accordingly without crashing or spiking.
Once predictable blood sugar patterns emerge, you can make medication or lifestyle changes to help prevent future high and low blood sugar levels. Additionally, many CGM systems also have low and high blood sugar level alerts, which can help you be proactive before they become dangerous—especially overnight.
Remote technology, such as the Dexcom Share feature, also allows users to share their data directly with providers and family who may want to keep a watch on their loved one’s blood sugar levels—and be alerted if they’re experiencing low or high blood sugar levels.
Some CGM systems are now integrated with insulin pump technology, which helps people with diabetes by making insulin dosing adjustments (changes to basal or bolus insulin) based on blood sugar level readings from the CGM!
Not only do CGMs save lives, but they lessen the nonstop mental burden of diabetes as well.
The Dexcom CGM system has shown to lower A1C, reduce both high and low blood sugar levels and improve time-in-range (TIR).
The Dexcom ONE system
The Dexcom One system is for people with any type of diabetes, who are older than two years and on insulin. This real-time CGM system is approved for no fingersticks, scanning or calibrations.
Users can wear this water-resistant device for ten days and it will read blood sugar levels once every five minutes—for a total of 288 readings per day.
The Dexcom ONE system is straightforward, with optional alerts that the user sets on their own. However, they aren’t able to automatically share readings with followers. This can be a good, more affordable option for adults and people without hypo-unawareness.
A CGM that offers reliable, consistent readings without the bells and whistles of the G6 or G7.
How to get a Dexcom ONE CGM
People with diabetes in France aren’t limited to the Dexcom ONE, however this launch can offer a more affordable choice.
“We believe this is truly exciting news for people living with diabetes in France,” said Gérald Zammit, country director of Dexcom France. “Access to Dexcom real-time CGM sensors is now available to those who live with diabetes, who aren’t necessarily seen as high risk, but who can still greatly benefit from it. The launch of Dexcom ONE in France will help to make real-time CGM accessible to as many patients as possible.”
Talk with your doctor if you’re interested in learning more about the Dexcom ONE system and how you can incorporate it into your diabetes management.
